Testosterone Therapy Safe Despite Prostate Cancer
New studies find no increase in biochemical recurrence risk following radical prostatectomy or radiation therapy associated with testosterone replacement therapy.
New studies find no increase in biochemical recurrence risk following radical prostatectomy or radiation therapy associated with testosterone replacement therapy.
A study of American men showed that those who adhered to a low-fat diet were twice as likely as men consuming usual diets to have hypogonadism.
Estradiol independently linked to leucocyte telomere length in older men; SHBG inversely associated
Despite research suggesting that there may be increased cardiovascular risk from off-label prescription testosterone use, usage in men with coronary artery disease remains higher than in men without coronary artery disease.
Considerable increase seen from 1997 through 2016, especially in direct-to-consumer advertising
Hypogonadism and serum testosterone evaluation nearly doubled the odds a man would undergo varicocelectomy.
More than half of UK specialists surveyed said measuring testosterone levels in patients with nonmetastatic prostate cancer was not their routine practice.
In a study, the rate of deep vein thrombosis in treated hypogonadal men was just 0.8% over 2 years of follow-up.
Meta-analysis suggests that testosterone treatment enhances mood in hypogonadal and eugonadal men.
In a study, older men with difficulty walking or climbing stairs reported better physical function after testosterone therapy.